Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 9, 2020 Off

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

By BusinessWire

SHANGHAI & ST. HELIER, Jersey–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and…

January 9, 2020 Off

Tiziana Reports Phase 1 Clinical Data Demonstrating Oral Treatment with Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, is Well-tolerated in Healthy Volunteers

By BusinessWire

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK & LONDON–(BUSINESS WIRE)–Tiziana…

January 9, 2020 Off

Tiziana Reports Phase 1 Clinical Data Demonstrating Oral Treatment with Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, is Well-tolerated in Healthy Volunteers

By BusinessWire

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK & LONDON–(BUSINESS WIRE)–Tiziana…

January 9, 2020 Off

Brady Davis Joins Contextual Genomics’ Executive Team

By BusinessWire

VANCOUVER, British Columbia–(BUSINESS WIRE)–#cancergenomics–Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive…

January 9, 2020 Off

Brady Davis Joins Contextual Genomics’ Executive Team

By BusinessWire

VANCOUVER, British Columbia–(BUSINESS WIRE)–#cancergenomics–Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive…

January 9, 2020 Off

Newron Announces Initiation of New Clinical Trial With Evenamide in Patients With Schizophrenia, Following Approval of Plan By FDA

By BusinessWire

MILAN & MORRISTOWN, N.J.–(BUSINESS WIRE)–$NWRN—Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of…

January 9, 2020 Off

Newron Announces Initiation of New Clinical Trial With Evenamide in Patients With Schizophrenia, Following Approval of Plan By FDA

By BusinessWire

MILAN & MORRISTOWN, N.J.–(BUSINESS WIRE)–$NWRN—Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of…

January 9, 2020 Off

F-star Therapeutics Appoints Dr. Edward Benz and Mr. Geoff Race to Board of Directors

By BusinessWire

CAMBRIDGE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with…

January 9, 2020 Off

F-star Therapeutics Appoints Dr. Edward Benz and Mr. Geoff Race to Board of Directors

By BusinessWire

CAMBRIDGE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with…

January 9, 2020 Off

Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial

By BusinessWire

SALT LAKE CITY–(BUSINESS WIRE)–#AlucentBiomedical—Alucent Biomedical Inc. has received U.S. Food and Drug Administration approval to proceed with a Phase 1…

Posts pagination

Previous 1 … 5,215 5,216 5,217 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine